0ZF Stock Overview
Operates as a cannabis company in the United States. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Vireo Growth Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.33 |
52 Week High | CA$0.63 |
52 Week Low | CA$0.19 |
Beta | 1.33 |
11 Month Change | -15.98% |
3 Month Change | -22.38% |
1 Year Change | 48.18% |
33 Year Change | -75.11% |
5 Year Change | -69.25% |
Change since IPO | -92.67% |
Recent News & Updates
Recent updates
Shareholder Returns
0ZF | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | -14.2% | -5.0% | -1.3% |
1Y | 48.2% | -22.0% | 7.4% |
Return vs Industry: 0ZF exceeded the German Pharmaceuticals industry which returned -21.6% over the past year.
Return vs Market: 0ZF exceeded the German Market which returned 7.1% over the past year.
Price Volatility
0ZF volatility | |
---|---|
0ZF Average Weekly Movement | 19.9% |
Pharmaceuticals Industry Average Movement | 6.9% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.8% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 0ZF's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 0ZF's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 438 | Amber Shimpa | vireohealth.com |
Vireo Growth Inc. operates as a cannabis company in the United States. The company cultivates, manufactures, processes, and distributes medical and adult-use cannabis products. It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York.
Vireo Growth Inc. Fundamentals Summary
0ZF fundamental statistics | |
---|---|
Market cap | €78.64m |
Earnings (TTM) | -€16.11m |
Revenue (TTM) | €94.00m |
0.8x
P/S Ratio-4.8x
P/E RatioIs 0ZF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0ZF income statement (TTM) | |
---|---|
Revenue | US$98.53m |
Cost of Revenue | US$48.36m |
Gross Profit | US$50.17m |
Other Expenses | US$67.06m |
Earnings | -US$16.89m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.073 |
Gross Margin | 50.92% |
Net Profit Margin | -17.14% |
Debt/Equity Ratio | -526.9% |
How did 0ZF perform over the long term?
See historical performance and comparison